TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03018873 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03018873 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03018873 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT00616720 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02450851 — Predictive Biomarker (PRD): WNT2 mRNA
Genes: WNT2; INT1L1; IRP
Study NCT04074135 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT03424993 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04194827 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05470777 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05470777 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00955578 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06624657 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02404337 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT01022489 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT01171755 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01171755 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT00535405 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02499471 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT03254914 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02572024 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04439253 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT00280202 — Predictive Biomarker (PRD): FADD mRNA
Genes: FADD; MORT1; GIG3
Study NCT04200963 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study NCT04200963 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT00741728 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06565351 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00973128 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00924092 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03113487 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00480805 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02769104 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01993082 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02693639 — Predictive Biomarker (PRD): PANX1 mRNA
Genes: PANX1; MRS1; UNQ2529/PRO6028
Study NCT04389060 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02256748 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01705392 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01705392 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01705392 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00651287 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03690245 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT01829451 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02327169 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT01334255 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00427037 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04049669 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT05731557 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01594567 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00443846 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT01639391 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT06136897 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01512966 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04225390 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04008420 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00554801 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT04605666 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04064905 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00995514 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03068000 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02387749 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02387749 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02387749 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00718432 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02746055 — Predictive Biomarker (PRD): TGFBI mRNA
Genes: TGFBI; BIGH3
Study NCT00567554 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02511288 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02511288 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT01772654 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT00895505 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01706185 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study NCT01706185 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT01706185 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT01771900 — Predictive Biomarker (PRD): CAMP mRNA
Genes: CAMP; CAP18; FALL39; HSD26
Study NCT01366625 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01596114 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01596114 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01928394 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04069468 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT02317016 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT02317016 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02317016 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02146872 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study NCT00890786 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03012230 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT00283374 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study NCT00970723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02888535 — Predictive Biomarker (PRD): HYLS1 mRNA
Genes: HYLS1; HLS
Study NCT03874559 — Predictive Biomarker (PRD): LRP1 mRNA
Genes: LRP1; A2MR; APR
Study NCT03874559 — Predictive Biomarker (PRD): PTPRF mRNA
Genes: PTPRF; LAR
Study NCT00005113 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT02757885 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03601897 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT04073732 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02721225 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT02721225 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02104609 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT01249092 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01249092 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT02484534 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03887546 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT01549314 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02313441 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04437979 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03523910 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03523910 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01088906 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT05231018 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05381662 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04278820 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT01672840 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02061111 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT04128566 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT04422899 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02735486 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03375242 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04446052 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03840967 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02400684 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02014467 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02930278 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03321643 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03321643 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00004128 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04189484 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03454035 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03454035 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02884453 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT02884453 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04535206 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04535206 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04535206 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03364504 — Predictive Biomarker (PRD): ABCC6 mRNA
Genes: ABCC6; ARA; MRP6
Study NCT00697229 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT01661283 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01661283 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01661283 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04443452 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04443452 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00001421 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05001906 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001406 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00601900 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00601900 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00166985 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00166985 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00851942 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00851942 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03477422 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT03498716 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00760552 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02057718 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study NCT00509288 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00339469 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00339469 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03949517 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01777477 — Predictive Biomarker (PRD): GOLM1 mRNA
Genes: GOLM1; C9orf155; GOLPH2; PSEC0242; UNQ686/PRO1326
Study NCT02824679 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT01003223 — Predictive Biomarker (PRD): PKM mRNA
Genes: PKM; OIP3; PK2; PK3; PKM2
Study NCT05105724 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT00217672 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00217672 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01674140 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01674140 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00546520 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT00546520 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01661543 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03048331 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT01722669 — Predictive Biomarker (PRD): P4HB mRNA
Genes: P4HB; ERBA2L; PDI; PDIA1; PO4DB
Study NCT02927964 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study NCT03987763 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT04163757 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03232268 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04340245 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT02884583 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05506098 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT04936438 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study NCT00117988 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03509623 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03509623 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04111458 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05960214 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03667820 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01319565 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01302886 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study NCT01302886 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00388609 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02048709 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT02383784 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02383784 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02383784 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02383784 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00649584 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03405012 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03357224 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04486729 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06058182 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study NCT00371020 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT03644537 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study NCT01027676 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01027676 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00117364 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00117364 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01331590 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04593797 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01162759 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02285881 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03418324 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02840994 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02544048 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02544048 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02633189 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03680521 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02576626 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03503409 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04117191 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study NCT04117191 — Predictive Biomarker (PRD): SULT1A1 mRNA
Genes: SULT1A1; STP; STP1; OK/SW-cl.88
Study NCT06561802 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT03078959 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03586531 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00426686 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT00426686 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04662203 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00964184 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04770207 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04361279 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02248571 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02248571 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00924274 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT00924274 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00473174 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00397540 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00569946 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00762463 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02610361 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT03521323 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03477812 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02675972 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01836354 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00659425 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01976689 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02242929 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study NCT02332668 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT01581554 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01733316 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02460458 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00149630 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study NCT00689884 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04035031 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01507740 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01507740 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT01507740 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02434861 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT02434861 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02434861 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02434861 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02434861 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT02434861 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01434303 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02520791 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study NCT02590081 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01037530 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03002844 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03465007 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00852618 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT01776294 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03237702 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT02965716 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01300637 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01300637 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01300637 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02733913 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02809300 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2